Skip to main content
. Author manuscript; available in PMC: 2014 Jun 3.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007223. doi: 10.1002/14651858.CD007223.pub2

Comparison 16.

Vaginal prostaglandin E1 (gemeprost) versus surgery

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Complete miscarriage 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.1 Gestation < 13 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 1.2 Gestation 13-23 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 1.3 Gestation not specified 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Surgical evacuation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 2.1 Gestation < 13 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 2.2 Gestation 13-23 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 2.3 Gestation not specified 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Death or serious complication 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 3.1 Gestation < 13 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 3.2 Gestation 13-23 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 3.3 Gestation not specified 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Unplanned surgical intervention 1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 4.1 Gestation < 13 weeks 1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 4.2 Gestation 13-23 weeks 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 4.3 Gestation not specified 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]